APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biobanking LIMS Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biobanking LIMS Software Market Analysis and Forecast 2026-2032

4 July 2026180 pages

Choose your research edition.

Industry ResearchBiobanking LIMS Software Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Biobanking LIMS Software Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Biobanking LIMS Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biobanking LIMS Software Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Biobanking LIMS Software Market Analysis and Forecast 2026-2032180 pages · $4,950 USD

Market perspective

The global Biobanking LIMS Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biobanking LIMS Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biobanking LIMS Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biobanking LIMS Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biobanking LIMS Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biobanking LIMS Software include Cell&Co BioServices, RUCDR LIMS, Csols, Agilent Technologies, CloudLIMS, LabCollector, OpenSpecimen, BSI Systems and TDBioBank, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biobanking LIMS Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biobanking LIMS Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Biobanking LIMS Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biobanking LIMS Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biobanking LIMS Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biobanking LIMS Software revenue, projected growth trends, production technology, application and end-user industry.

Biobanking LIMS Software Segment by Company

Cell&Co BioServices

RUCDR LIMS

Csols

Agilent Technologies

CloudLIMS

LabCollector

OpenSpecimen

BSI Systems

TDBioBank

Autoscribe

LabVantage

Thermo Fisher Scientific

Ocimum Biosolutions

LabKey

Azenta US

Modul-Bio

LIMSABC

Biobanking LIMS Software Segment by Type

Cloud Based

On-Premise

Biobanking LIMS Software Segment by Application

Regenerative Medicine

Life Science

Clinical Research

Biobanking LIMS Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking LIMS Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biobanking LIMS Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking LIMS Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biobanking LIMS Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biobanking LIMS Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biobanking LIMS Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biobanking LIMS Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud Based Major Player Table 3. On-Premise Major Player Table 4. Global Biobanking LIMS Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Regenerative Medicine Major Player Table 6. Life Science Major Player Table 7. Clinical Research Major Player Table 8. Biobanking LIMS Software Industry Trends Table 9. Biobanking LIMS Software Industry Drivers Table 10. Biobanking LIMS Software Industry Opportunities and Challenges Table 11. Biobanking LIMS Software Industry Restraints Table 12. Global Biobanking LIMS Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Biobanking LIMS Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Biobanking LIMS Software Market Share by Region (2021-2026) Table 15. Global Biobanking LIMS Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Biobanking LIMS Software Market Share by Region (2027-2032) Table 17. Global Biobanking LIMS Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Biobanking LIMS Software Revenue Market Share by Players (2021-2026) Table 19. Global Biobanking LIMS Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biobanking LIMS Software Key Players Headquarters & Area Served Table 21. Global Biobanking LIMS Software Players, Product Type & Application Table 22. Global Biobanking LIMS Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Biobanking LIMS Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Biobanking LIMS Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biobanking LIMS Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Biobanking LIMS Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Biobanking LIMS Software Revenue Market Share by Type (2021-2026) Table 29. Global Biobanking LIMS Software Revenue Market Share by Type (2027-2032) Table 30. Global Biobanking LIMS Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biobanking LIMS Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Biobanking LIMS Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Biobanking LIMS Software Revenue Market Share by Application (2021-2026) Table 34. Global Biobanking LIMS Software Revenue Market Share by Application (2027-2032) Table 35. Cell&Co BioServices Company Information Table 36. Cell&Co BioServices Business Overview Table 37. Cell&Co BioServices Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Cell&Co BioServices Biobanking LIMS Software Product Portfolio Table 39. Cell&Co BioServices Recent Development Table 40. RUCDR LIMS Company Information Table 41. RUCDR LIMS Business Overview Table 42. RUCDR LIMS Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. RUCDR LIMS Biobanking LIMS Software Product Portfolio Table 44. RUCDR LIMS Recent Development Table 45. Csols Company Information Table 46. Csols Business Overview Table 47. Csols Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Csols Biobanking LIMS Software Product Portfolio Table 49. Csols Recent Development Table 50. Agilent Technologies Company Information Table 51. Agilent Technologies Business Overview Table 52. Agilent Technologies Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Agilent Technologies Biobanking LIMS Software Product Portfolio Table 54. Agilent Technologies Recent Development Table 55. CloudLIMS Company Information Table 56. CloudLIMS Business Overview Table 57. CloudLIMS Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. CloudLIMS Biobanking LIMS Software Product Portfolio Table 59. CloudLIMS Recent Development Table 60. LabCollector Company Information Table 61. LabCollector Business Overview Table 62. LabCollector Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. LabCollector Biobanking LIMS Software Product Portfolio Table 64. LabCollector Recent Development Table 65. OpenSpecimen Company Information Table 66. OpenSpecimen Business Overview Table 67. OpenSpecimen Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. OpenSpecimen Biobanking LIMS Software Product Portfolio Table 69. OpenSpecimen Recent Development Table 70. BSI Systems Company Information Table 71. BSI Systems Business Overview Table 72. BSI Systems Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. BSI Systems Biobanking LIMS Software Product Portfolio Table 74. BSI Systems Recent Development Table 75. TDBioBank Company Information Table 76. TDBioBank Business Overview Table 77. TDBioBank Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. TDBioBank Biobanking LIMS Software Product Portfolio Table 79. TDBioBank Recent Development Table 80. Autoscribe Company Information Table 81. Autoscribe Business Overview Table 82. Autoscribe Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Autoscribe Biobanking LIMS Software Product Portfolio Table 84. Autoscribe Recent Development Table 85. LabVantage Company Information Table 86. LabVantage Business Overview Table 87. LabVantage Biobanking LIMS Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. LabVantage Biobanking LIMS Software Product Portfolio Table 89. LabVantage Recent Development Table 90. Thermo Fisher Scientific Company Information Table 91. Thermo Fisher Scientific Business Overview Table 92. Thermo Fisher Scientific Biobanking LIMS Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Thermo Fisher Scientific Biobanking LIMS Software Product Portfolio Table 94. Thermo Fisher Scientific Recent Development Table 95. Ocimum Biosolutions Company Information Table 96. Ocimum Biosolutions Business Overview Table 97. Ocimum Biosolutions Biobanking LIMS Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Ocimum Biosolutions Biobanking LIMS Software Product Portfolio Table 99. Ocimum Biosolutions Recent Development Table 100. LabKey Company Information Table 101. LabKey Business Overview Table 102. LabKey Biobanking LIMS Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. LabKey Biobanking LIMS Software Product Portfolio Table 104. LabKey Recent Development Table 105. Azenta US Company Information Table 106. Azenta US Business Overview Table 107. Azenta US Biobanking LIMS Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Azenta US Biobanking LIMS Software Product Portfolio Table 109. Azenta US Recent Development Table 110. Modul-Bio Company Information Table 111. Modul-Bio Business Overview Table 112. Modul-Bio Biobanking LIMS Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Modul-Bio Biobanking LIMS Software Product Portfolio Table 114. Modul-Bio Recent Development Table 115. LIMSABC Company Information Table 116. LIMSABC Business Overview Table 117. LIMSABC Biobanking LIMS Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. LIMSABC Biobanking LIMS Software Product Portfolio Table 119. LIMSABC Recent Development Table 120. North America Biobanking LIMS Software Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Biobanking LIMS Software Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Biobanking LIMS Software Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Biobanking LIMS Software Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Biobanking LIMS Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Biobanking LIMS Software Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Biobanking LIMS Software Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Biobanking LIMS Software Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Biobanking LIMS Software Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Biobanking LIMS Software Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Biobanking LIMS Software Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Biobanking LIMS Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Biobanking LIMS Software Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Biobanking LIMS Software Revenue by Country (US$ Million) & (2027-2032) Table 134. China Biobanking LIMS Software Revenue by Type (2021-2026) & (US$ Million) Table 135. China Biobanking LIMS Software Revenue by Type (2027-2032) & (US$ Million) Table 136. China Biobanking LIMS Software Revenue by Application (2021-2026) & (US$ Million) Table 137. China Biobanking LIMS Software Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Biobanking LIMS Software Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Biobanking LIMS Software Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Biobanking LIMS Software Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Biobanking LIMS Software Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Biobanking LIMS Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Biobanking LIMS Software Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Biobanking LIMS Software Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Biobanking LIMS Software Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Biobanking LIMS Software Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Biobanking LIMS Software Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Biobanking LIMS Software Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Biobanking LIMS Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Biobanking LIMS Software Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Biobanking LIMS Software Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Biobanking LIMS Software Image Figure 2. Global Biobanking LIMS Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biobanking LIMS Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud Based Image Figure 5. On-Premise Image Figure 6. Global Biobanking LIMS Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biobanking LIMS Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Regenerative Medicine Image Figure 9. Life Science Image Figure 10. Clinical Research Image Figure 11. Global Biobanking LIMS Software Market Size (US$ Million) & (2021-2032) Figure 12. Global Biobanking LIMS Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biobanking LIMS Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Biobanking LIMS Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Biobanking LIMS Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biobanking LIMS Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Biobanking LIMS Software Revenue Market Share by Type (2021-2032) Figure 19. Global Biobanking LIMS Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biobanking LIMS Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Biobanking LIMS Software Revenue Market Share by Application (2021-2032) Figure 22. North America Biobanking LIMS Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Biobanking LIMS Software Revenue Share by Type (2021-2032) Figure 24. North America Biobanking LIMS Software Revenue Share by Application (2021-2032) Figure 25. North America Biobanking LIMS Software Revenue Share by Country (2021-2032) Figure 26. United States Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Biobanking LIMS Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Biobanking LIMS Software Revenue Share by Type (2021-2032) Figure 31. Europe Biobanking LIMS Software Revenue Share by Application (2021-2032) Figure 32. Europe Biobanking LIMS Software Revenue Share by Country (2021-2032) Figure 33. Germany Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Biobanking LIMS Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Biobanking LIMS Software Revenue Share by Type (2021-2032) Figure 43. China Biobanking LIMS Software Revenue Share by Application (2021-2032) Figure 44. Asia Biobanking LIMS Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Biobanking LIMS Software Revenue Share by Type (2021-2032) Figure 46. Asia Biobanking LIMS Software Revenue Share by Application (2021-2032) Figure 47. Asia Biobanking LIMS Software Revenue Share by Region (2021-2032) Figure 48. Japan Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Biobanking LIMS Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Biobanking LIMS Software Revenue Share by Type (2021-2032) Figure 56. SAMEA Biobanking LIMS Software Revenue Share by Application (2021-2032) Figure 57. SAMEA Biobanking LIMS Software Revenue Share by Country (2021-2032) Figure 58. Brazil Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Biobanking LIMS Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • On-Premise
Applications
  • Regenerative Medicine
  • Life Science
  • Clinical Research
Companies covered
  • Cell&Co BioServices
  • RUCDR LIMS
  • Csols
  • Agilent Technologies
  • CloudLIMS
  • LabCollector
  • OpenSpecimen
  • BSI Systems
  • TDBioBank
  • Autoscribe
  • LabVantage
  • Thermo Fisher Scientific
  • Ocimum Biosolutions
  • LabKey
  • Azenta US
  • Modul-Bio
  • LIMSABC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biobanking LIMS Software Market by Type
  3. 1.2.1 Global Biobanking LIMS Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud Based
  5. 1.2.3 On-Premise
  6. 1.3 Biobanking LIMS Software Market by Application
  7. 1.3.1 Global Biobanking LIMS Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Regenerative Medicine
  9. 1.3.3 Life Science
  10. 1.3.4 Clinical Research
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Biobanking LIMS Software Market Dynamics
  1. 2.1 Biobanking LIMS Software Industry Trends
  2. 2.2 Biobanking LIMS Software Industry Drivers
  3. 2.3 Biobanking LIMS Software Industry Opportunities and Challenges
  4. 2.4 Biobanking LIMS Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biobanking LIMS Software Market Perspective (2021-2032)
  2. 3.2 Global Biobanking LIMS Software Growth Trends by Region
  3. 3.2.1 Global Biobanking LIMS Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biobanking LIMS Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Biobanking LIMS Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biobanking LIMS Software Revenue by Players
  2. 4.1.1 Global Biobanking LIMS Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Biobanking LIMS Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biobanking LIMS Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biobanking LIMS Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biobanking LIMS Software Key Players Headquarters & Area Served
  7. 4.4 Global Biobanking LIMS Software Players, Product Type & Application
  8. 4.5 Global Biobanking LIMS Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biobanking LIMS Software Market CR5 and HHI
  11. 4.6.3 2025 Biobanking LIMS Software Tier 1, Tier 2, and Tier 3
5 Biobanking LIMS Software Market Size by Type
  1. 5.1 Global Biobanking LIMS Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biobanking LIMS Software Revenue by Type (2021-2032)
  3. 5.3 Global Biobanking LIMS Software Revenue Market Share by Type (2021-2032)
6 Biobanking LIMS Software Market Size by Application
  1. 6.1 Global Biobanking LIMS Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biobanking LIMS Software Revenue by Application (2021-2032)
  3. 6.3 Global Biobanking LIMS Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cell&Co BioServices
  2. 7.1.1 Cell&Co BioServices Company Information
  3. 7.1.2 Cell&Co BioServices Business Overview
  4. 7.1.3 Cell&Co BioServices Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cell&Co BioServices Biobanking LIMS Software Product Portfolio
  6. 7.1.5 Cell&Co BioServices Recent Developments
  7. 7.2 RUCDR LIMS
  8. 7.2.1 RUCDR LIMS Company Information
  9. 7.2.2 RUCDR LIMS Business Overview
  10. 7.2.3 RUCDR LIMS Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 RUCDR LIMS Biobanking LIMS Software Product Portfolio
  12. 7.2.5 RUCDR LIMS Recent Developments
  13. 7.3 Csols
  14. 7.3.1 Csols Company Information
  15. 7.3.2 Csols Business Overview
  16. 7.3.3 Csols Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Csols Biobanking LIMS Software Product Portfolio
  18. 7.3.5 Csols Recent Developments
  19. 7.4 Agilent Technologies
  20. 7.4.1 Agilent Technologies Company Information
  21. 7.4.2 Agilent Technologies Business Overview
  22. 7.4.3 Agilent Technologies Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Agilent Technologies Biobanking LIMS Software Product Portfolio
  24. 7.4.5 Agilent Technologies Recent Developments
  25. 7.5 CloudLIMS
  26. 7.5.1 CloudLIMS Company Information
  27. 7.5.2 CloudLIMS Business Overview
  28. 7.5.3 CloudLIMS Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CloudLIMS Biobanking LIMS Software Product Portfolio
  30. 7.5.5 CloudLIMS Recent Developments
  31. 7.6 LabCollector
  32. 7.6.1 LabCollector Company Information
  33. 7.6.2 LabCollector Business Overview
  34. 7.6.3 LabCollector Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LabCollector Biobanking LIMS Software Product Portfolio
  36. 7.6.5 LabCollector Recent Developments
  37. 7.7 OpenSpecimen
  38. 7.7.1 OpenSpecimen Company Information
  39. 7.7.2 OpenSpecimen Business Overview
  40. 7.7.3 OpenSpecimen Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 OpenSpecimen Biobanking LIMS Software Product Portfolio
  42. 7.7.5 OpenSpecimen Recent Developments
  43. 7.8 BSI Systems
  44. 7.8.1 BSI Systems Company Information
  45. 7.8.2 BSI Systems Business Overview
  46. 7.8.3 BSI Systems Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BSI Systems Biobanking LIMS Software Product Portfolio
  48. 7.8.5 BSI Systems Recent Developments
  49. 7.9 TDBioBank
  50. 7.9.1 TDBioBank Company Information
  51. 7.9.2 TDBioBank Business Overview
  52. 7.9.3 TDBioBank Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 TDBioBank Biobanking LIMS Software Product Portfolio
  54. 7.9.5 TDBioBank Recent Developments
  55. 7.10 Autoscribe
  56. 7.10.1 Autoscribe Company Information
  57. 7.10.2 Autoscribe Business Overview
  58. 7.10.3 Autoscribe Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Autoscribe Biobanking LIMS Software Product Portfolio
  60. 7.10.5 Autoscribe Recent Developments
  61. 7.11 LabVantage
  62. 7.11.1 LabVantage Company Information
  63. 7.11.2 LabVantage Business Overview
  64. 7.11.3 LabVantage Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 LabVantage Biobanking LIMS Software Product Portfolio
  66. 7.11.5 LabVantage Recent Developments
  67. 7.12 Thermo Fisher Scientific
  68. 7.12.1 Thermo Fisher Scientific Company Information
  69. 7.12.2 Thermo Fisher Scientific Business Overview
  70. 7.12.3 Thermo Fisher Scientific Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Scientific Biobanking LIMS Software Product Portfolio
  72. 7.12.5 Thermo Fisher Scientific Recent Developments
  73. 7.13 Ocimum Biosolutions
  74. 7.13.1 Ocimum Biosolutions Company Information
  75. 7.13.2 Ocimum Biosolutions Business Overview
  76. 7.13.3 Ocimum Biosolutions Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Ocimum Biosolutions Biobanking LIMS Software Product Portfolio
  78. 7.13.5 Ocimum Biosolutions Recent Developments
  79. 7.14 LabKey
  80. 7.14.1 LabKey Company Information
  81. 7.14.2 LabKey Business Overview
  82. 7.14.3 LabKey Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 LabKey Biobanking LIMS Software Product Portfolio
  84. 7.14.5 LabKey Recent Developments
  85. 7.15 Azenta US
  86. 7.15.1 Azenta US Company Information
  87. 7.15.2 Azenta US Business Overview
  88. 7.15.3 Azenta US Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Azenta US Biobanking LIMS Software Product Portfolio
  90. 7.15.5 Azenta US Recent Developments
  91. 7.16 Modul-Bio
  92. 7.16.1 Modul-Bio Company Information
  93. 7.16.2 Modul-Bio Business Overview
  94. 7.16.3 Modul-Bio Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Modul-Bio Biobanking LIMS Software Product Portfolio
  96. 7.16.5 Modul-Bio Recent Developments
  97. 7.17 LIMSABC
  98. 7.17.1 LIMSABC Company Information
  99. 7.17.2 LIMSABC Business Overview
  100. 7.17.3 LIMSABC Biobanking LIMS Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 LIMSABC Biobanking LIMS Software Product Portfolio
  102. 7.17.5 LIMSABC Recent Developments
8 North America
  1. 8.1 North America Biobanking LIMS Software Revenue (2021-2032)
  2. 8.2 North America Biobanking LIMS Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Biobanking LIMS Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Biobanking LIMS Software Revenue by Type (2027-2032)
  5. 8.3 North America Biobanking LIMS Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Biobanking LIMS Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Biobanking LIMS Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Biobanking LIMS Software Revenue by Application (2027-2032)
  9. 8.5 North America Biobanking LIMS Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Biobanking LIMS Software Revenue by Country
  11. 8.6.1 North America Biobanking LIMS Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biobanking LIMS Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Biobanking LIMS Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biobanking LIMS Software Revenue (2021-2032)
  2. 9.2 Europe Biobanking LIMS Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biobanking LIMS Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biobanking LIMS Software Revenue by Type (2027-2032)
  5. 9.3 Europe Biobanking LIMS Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biobanking LIMS Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biobanking LIMS Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biobanking LIMS Software Revenue by Application (2027-2032)
  9. 9.5 Europe Biobanking LIMS Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biobanking LIMS Software Revenue by Country
  11. 9.6.1 Europe Biobanking LIMS Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biobanking LIMS Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biobanking LIMS Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biobanking LIMS Software Revenue (2021-2032)
  2. 10.2 China Biobanking LIMS Software Revenue by Type (2021-2032)
  3. 10.2.1 China Biobanking LIMS Software Revenue by Type (2021-2026)
  4. 10.2.2 China Biobanking LIMS Software Revenue by Type (2027-2032)
  5. 10.3 China Biobanking LIMS Software Revenue Share by Type (2021-2032)
  6. 10.4 China Biobanking LIMS Software Revenue by Application (2021-2032)
  7. 10.4.1 China Biobanking LIMS Software Revenue by Application (2021-2026)
  8. 10.4.2 China Biobanking LIMS Software Revenue by Application (2027-2032)
  9. 10.5 China Biobanking LIMS Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biobanking LIMS Software Revenue (2021-2032)
  2. 11.2 Asia Biobanking LIMS Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biobanking LIMS Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biobanking LIMS Software Revenue by Type (2027-2032)
  5. 11.3 Asia Biobanking LIMS Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biobanking LIMS Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biobanking LIMS Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biobanking LIMS Software Revenue by Application (2027-2032)
  9. 11.5 Asia Biobanking LIMS Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biobanking LIMS Software Revenue by Country
  11. 11.6.1 Asia Biobanking LIMS Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biobanking LIMS Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biobanking LIMS Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biobanking LIMS Software Revenue (2021-2032)
  2. 12.2 SAMEA Biobanking LIMS Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biobanking LIMS Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biobanking LIMS Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biobanking LIMS Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biobanking LIMS Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biobanking LIMS Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biobanking LIMS Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biobanking LIMS Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biobanking LIMS Software Revenue by Country
  11. 12.6.1 SAMEA Biobanking LIMS Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biobanking LIMS Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biobanking LIMS Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst